A Randomized Phase II Study of Brentuximab Vedotin (NSC# 749710) and Crizotinib (NSC# 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL)IND #117117

Submitted by centretek on Sat, 10/15/2022 - 10:29

Source URL

https://www.inova.org/clinical-trials/randomized-phase-2-study-brentuximab-vedotin-nsc-749710-and-crizotinib-nsc-749005

Description

General Information Age Group Pediatrics/Children Status Active Protocol Number ANHL12P1 Offered At Inova Children's Hospital 3300 Gallows Road Falls Church, VA 22042 Contact Information Contact Name Keary Jane't Contact Phone 703-776-3456 Contact Email Send Email

Clinical Trials Category

Cancer

Clinical Trials Sub categories

Lymphoma

Crawled Content Type

Clinical Trials